You are here

Human Longevity, Inc.

Member Since 2017

Travis Lacey

Chief Corporate Development Officer

Travis Lacey has more than 20 years of experience in healthcare across functions including investment banking, business development, and operations. During his career, he has successfully led over fifty mergers and acquisitions and financing transactions with significant domain and functional expertise across the healthcare landscape, including pharma, devices and healthcare services.

Lacey joined HLI from GE Healthcare where he was managing director leading the divestiture practice and portfolio optimization across the $18B GE Healthcare platform. Prior to GE Healthcare, Lacey spent nine years in healthcare investment banking at Jefferies and Co., Inc. and Robert W. Baird & Co., Inc. where he was responsible for sourcing and leading merger and acquisitions and financing transactions. Prior to that, he spent the first ten years of his career at Abbott Laboratories where he held multiple positions across operations, manufacturing technology and quality.

Lacey received his Bachelor of Science in Statistics from University of Tennessee, Knoxville and his MBA from Northwestern University’s Kellogg School of Management.

Human Longevity, Inc.

Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI’s business focus includes the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health. For more information, please visit